Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Consulting agrmnt Inv. presentation
|
Eloxx Pharmaceuticals, Inc. (ELOX)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
04/19/2018 |
10-K/A
| Annual Report for the period ended December 31, 2017 [amend] |
11/16/2016 |
10-K/A
| Annual Report for the period ended June 30, 2016 [amend] |
10/28/2016 |
10-K/A
| Annual Report for the period ended June 30, 2016 [amend] |
10/28/2015 |
10-K/A
| Annual Report for the period ended June 30, 2015 [amend] |
09/25/2013 |
10-K/A
| Annual Report for the period ended June 30, 2013 [amend] |
10/26/2012 |
10-K/A
| Annual Report for the period ended June 30, 2012 [amend] |
10/24/2011 |
10-K/A
| Annual Report for the period ended June 30, 2011 [amend] |
10/25/2010 |
10-K/A
| Annual Report for the period ended June 30, 2010 [amend] |
10/28/2009 |
10-K/A
| Annual Report for the period ended June 30, 2009 [amend] |
10/29/2007 |
10-K/A
| Annual Report for the period ended June 30, 2007 [amend] |
|
|